Common Antacid can Treat Tuberculosis: Swiss Federal Institute Of Technology

Switzerland researchers found that an antacid called Lansoprazole is effective against M. tuberculosis but only when the bacterium grows inside the cells.

To help fight against the global pandemic tuberculosis that kills nearly 1.5 million people a year, scientists have identified an over-the-counter antacid.

The team from the Swiss Federal Institute of Technology in Lausanne, Switzerland found the antacid called Lansoprazole to be effective against M. tuberculosis but only when the bacterium grows inside cells.

Daily Popping an Antacid to Regulate Stomach Acid Increases Heart Attack Risk
People who take antacids or medication to suppress stomach acid are at greater risk of developing myocardial infarction, commonly known as heart attack.

The researchers examined the underlying biology and found that Lansoprazole kills the bacterium after the human cells convert it into a sulphur-containing metabolite. It targets a particular enzyme that is crucial for the bacterium to produce energy, thereby killing it off.

"Being highly active against drug-resistant strains of M. tuberculosis, this novel class of drugs provides us with an excellent opportunity to treat tuberculosis," said lead researcher Stewart Cole.

In addition, when the scientists tested Lansoprazole against a wide range of other bacteria, it proved to be highly selective for M. tuberculosis, said the study published in the journal Nature Communications.

Better Survival in Head and Neck Cancer in Antacid Users
Better overall survival was seen in patients with head and neck cancer who used antacid medicines to control acid reflux, found a new study from the University of Michigan Comprehensive Cancer Center.

The EPFL researchers used a method they had previously developed which can reflect what happens when the bacterium infects a lung much better than conventional screening assays used in tuberculosis research.

The scientists screened a large panel of already approved drugs, and identified the blockbuster antacid Lansoprazole, known commercially as Prevacid, as a potential anti-tuberculosis medication.

Common Antacids can Act as Cheaper Anti-cancer Drugs
A recent research has proved that increased survival in colorectal cancer is possible with the use of a popular indigestion medication.

Lansoprazole belongs to a class of drugs known as "proton-pump inhibitors" that keep the stomach from pumping too much acid, thus preventing heartburn and ulcers.

Source-IANS

Research Says Antacids may Lead to 'Difficult to Treat' Small Intestine Ulcers
Antacids that we take to reduce the chances of stomach ulcers we think can be caused by arthritis drugs, may result in irreparable harm to the small intestine, a new McMaster study has revealed